TY  - JOUR
AU  - Espejo-Roman, Jose M
AU  - Rubio-Ruiz, Belen
AU  - Cano-Cortes, Victoria
AU  - Cruz-Lopez, Olga
AU  - Gonzalez-Resines, Saul
AU  - Domene, Carmen
AU  - Conejo-Garcia, Ana
AU  - Sanchez-Martin, Rosario M
PY  - 2022
DO  - 10.3390/pharmaceutics14040788
SN  - 1999-4923
UR  - http://hdl.handle.net/10668/21548
T2  - Pharmaceutics
AB  - Hyaluronic acid (HA), through its interactions with the cluster of differentiation 44 (CD44), acts as a potent modulator of the tumor microenvironment, creating a wide range of extracellular stimuli for tumor growth, angiogenesis, invasion, and...
LA  - en
PB  - MDPI AG
KW  - anticancer therapy
KW  - cluster of differentiation 44
KW  - hyaluronic acid
KW  - molecular dynamics simulations
KW  - nanomedicine
KW  - selective release
KW  - tetrahydroisoquinoline
KW  - Hyaluronic Acid
KW  - Cell Movement
KW  - Binding Sites
KW  - Neovascularization, Pathologic
KW  - Neoplastic Processes
KW  - Neoplasms
KW  - Tumor Microenvironment
KW  - Drug Liberation
KW  - Cell Survival
TI  - Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.
TY  - research article
VL  - 14
ER  -